Sanofi Chews The Fat: Rimonabant Anti-Obesity NDA To Be Filed By 2005

Sanofi-Synthelabo expects to file an NDA for rimonabant in obesity by the first quarter of 2005, Exec VP-Scientific Affairs Gerard Le Fur told analysts during a business review in London Sept. 2